86-21-69018966

cpd-service@caerulumpharma.com

Home
About Us
Products
Solutions
Resources
- Downloadable
- Image gallery
FAQs
Contact Us

Home
RPC-1063

Products Categories

Antineoplastic
- ACC
- Adenosine A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- AXL
- BCl2-BH4
- Bcr-Abl
- BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating agent
- EED
- EGFR
- EP4
- ER
- FAK
- FGFR
- FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Hypoglycemic drugs
Others
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-kB
- NRTI
- PPAR
- RIP1
- S1PR
- SGC
- SYK
- α2δ-1
- αIIbβ3
- β2-adrenoceptor
- σ1

RPC-1063 - Manufacturers, Factory, Suppliers From China

RPC-1063, , , , RPC-1063,

Wholesale RPC 1063 - THZ2 – Caeruleum
Top Quality Glycopyrrolate Pure - CAS: 1896262...
2018 Latest Design Potassium Iodide Price - Os...
Excellent quality 1693758-51-8 - AZD8186 ̵...
Special Price for Miltefosine Manufacturers - ...
100% Original 6 – Lactaminic Acid - Pozi...
High reputation DS 5565 - GSK-461364; GSK-4613...
High reputation CP45677 - Olodaterol Free base...
OEM/ODM Factory Steroids And Hormones - Ozanim...
Lowest Price for Thyroid Neoplasm - Olodaterol...
Factory For 1627494-13-6 - Bardoxolone methyl ...
Low MOQ for Antineoplastic 99% Nilotinib - Bat...

<< < Previous 1 2

Contact Us

No. 401, 4th Floor, Building 6, Quwu Road 589, Minhang District, 200241 Shanghai, China
86-21-69018966
Within China:
sales-cpd@caerulumpharma.com
International:
cpd-service@caerulumpharma.com

Inquiry

For inquiries about our products, please leave your email with us and we will be in touch within 24 hours.Inquiry

Latest News

Top 7 Trends In Pharmaceutical Research I...

Being under ever-increasing pressure to compete in a challenging economic and technological environment, pharmaceutical and biotech companies must continually innovate in their R&D programmes to stay ahead ...
ARS-1620: A promising new inhibitor for K...

According to a study published in Cell, researchers have developed a specific inhibitor for KRASG12C called ARS-1602 that induced tumor regression in mice. “This study provides in vivo evidence that mutant KRAS can be...
AstraZeneca receives regulatory boost for...

AstraZeneca received a double boost for its oncology portfolio on Tuesday, after US and European regulators accepted regulatory submissions for its drugs, the first step towards winning approval for these medicines. ...

© Copyright - 2015-2022 : All Rights Reserved.

FAQs
Downloadable
Contact Us

QR Code

WhatsApp Online Chat !